Home/Exosla Therapeutics/Pierre Arsène
PA

Pierre Arsène

Founder and Executive Chair

Exosla Therapeutics

Therapeutic Areas

Exosla Therapeutics Pipeline

DrugIndicationPhase
EV-based Neurorestorative TherapyNeurological injury in newborn infantsPre-clinical